<p>Groups of 5–10 C57Bl/6 mice were intranasally infected with 50 CFU SchuS4 in 25 µl. At the indicated time points after infection mice were injected intraperitoneally once daily with 40 (A) or 5 mg/kg (B) LVF diluted in 5% dextrose water. All mice were treated for 14 days. Thirty days after primary challenge all surviving animals (primary survivors) were re-challenged (secondary challenge) intranasally with 50 CFU SchuS4. * = p<0.05 compared to untreated controls and mice receiving antibiotic from day 3–16. ** = p<0.05 compared to untreated controls and mice receiving LVF on day 3. *** = p<0.05 compared untreated mice. Data in each graph is representative of 4 experiments of similar design.</p
(A-B) Groups of 5–9 C57Bl/6J mice were challenged by intranasal instillation with 2,000 (circles) or...
<p>C57BL/6J mice (n = 14/group) were challenged intradermally with 10-20 CFU of <i>F. tularensis</i>...
*<p>Groups of mice (n = 7) were followed for 20 days pi or until their death with doses ranging from...
<p>From a single challenge study, mice were exposed intranasally with Schu S4 (131 CFU), CipR mutant...
<p>(A) Balb/c mice (n = 10/group) were infected intradermally with the indicated number of <i>F. tul...
<p>C57BL/6 female mice (n = 5) were infected intradermally with different strains of <i>F. tularensi...
<p>(A) BALB/c mice (N = 5) were anesthetized and infected with various <i>F. tularensis</i> Schu S4 ...
<p>(<b>A</b>) Intracellular growth of <i>F. tularensis</i> SchuS4, ΔFTT0369c, ΔFTT1676 and ΔFTT0369c...
<p>Balb/c mice (n = 5–10/group) were infected intradermally (A) or intranasally (B) with approximate...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>αβTCR<sup>−/−</sup> (n = 5), γδTCR<sup>−/−</sup> (n = 10), µMT<sup>−/−</sup> (n = 5), SCID (n = 1...
<p>Groups of BALB/c mice (n = 10) were challenged and survival monitored following infection by intr...
<p>Duration of shedding of different strains of <i>S. pyogenes</i> (7×10<sup>8</sup> cfu per 5 µl do...
<p>C57BL/6 mice (n = 7–10) were vaccinated 2 times, 28 days apart, with either TMV-DOST with adjuvan...
<p>Female C57BL/6 mice (5/group) were treated with PBS or with 10, 100, 1000 µg of Acai PS by the in...
(A-B) Groups of 5–9 C57Bl/6J mice were challenged by intranasal instillation with 2,000 (circles) or...
<p>C57BL/6J mice (n = 14/group) were challenged intradermally with 10-20 CFU of <i>F. tularensis</i>...
*<p>Groups of mice (n = 7) were followed for 20 days pi or until their death with doses ranging from...
<p>From a single challenge study, mice were exposed intranasally with Schu S4 (131 CFU), CipR mutant...
<p>(A) Balb/c mice (n = 10/group) were infected intradermally with the indicated number of <i>F. tul...
<p>C57BL/6 female mice (n = 5) were infected intradermally with different strains of <i>F. tularensi...
<p>(A) BALB/c mice (N = 5) were anesthetized and infected with various <i>F. tularensis</i> Schu S4 ...
<p>(<b>A</b>) Intracellular growth of <i>F. tularensis</i> SchuS4, ΔFTT0369c, ΔFTT1676 and ΔFTT0369c...
<p>Balb/c mice (n = 5–10/group) were infected intradermally (A) or intranasally (B) with approximate...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>αβTCR<sup>−/−</sup> (n = 5), γδTCR<sup>−/−</sup> (n = 10), µMT<sup>−/−</sup> (n = 5), SCID (n = 1...
<p>Groups of BALB/c mice (n = 10) were challenged and survival monitored following infection by intr...
<p>Duration of shedding of different strains of <i>S. pyogenes</i> (7×10<sup>8</sup> cfu per 5 µl do...
<p>C57BL/6 mice (n = 7–10) were vaccinated 2 times, 28 days apart, with either TMV-DOST with adjuvan...
<p>Female C57BL/6 mice (5/group) were treated with PBS or with 10, 100, 1000 µg of Acai PS by the in...
(A-B) Groups of 5–9 C57Bl/6J mice were challenged by intranasal instillation with 2,000 (circles) or...
<p>C57BL/6J mice (n = 14/group) were challenged intradermally with 10-20 CFU of <i>F. tularensis</i>...
*<p>Groups of mice (n = 7) were followed for 20 days pi or until their death with doses ranging from...